Literature DB >> 23362465

Osteoclast fusion and regulation by RANKL-dependent and independent factors.

Lianping Xing1, Yan Xiu, Brendan F Boyce.   

Abstract

Osteoclasts are the bone resorbing cells essential for bone remodeling. Osteoclasts are formed from hematopoietic progenitors in the monocyte/macrophage lineage. Osteoclastogenesis is composed of several steps including progenitor survival, differentiation to mono-nuclear pre-osteoclasts, fusion to multi-nuclear mature osteoclasts, and activation to bone resorbing osteoclasts. The regulation of osteoclastogenesis has been extensively studied, in which the receptor activator of NF-κB ligand (RANKL)-mediated signaling pathway and downstream transcription factors play essential roles. However, less is known about osteoclast fusion, which is a property of mature osteoclasts and is required for osteoclasts to resorb bone. Several proteins that affect cell fusion have been identified. Among them, dendritic cell-specific transmembrane protein (DC-STAMP) is directly associated to osteoclast fusion in vivo. Cytokines and factors influence osteoclast fusion through regulation of DC-STAMP. Here we review the recently discovered new factors that regulate osteoclast fusion with specific focus on DC-STAMP. A better understanding of the mechanistic basis of osteoclast fusion will lead to the development of a new therapeutic strategy for bone disorders due to elevated osteoclast bone resorption. Cell-cell fusion is essential for a variety of cellular biological processes. In mammals, there is a limited number of cell types that fuse to form multinucleated cells, such as the fusion of myoblasts for the formation of skeletal muscle and the fusion of cells of the monocyte/macrophage lineage for the formation of multinucleated osteoclasts and giant cells. In most cases, cell-cell fusion is beneficial for cells by enhancing function. Myoblast fusion increases myofiber size and diameter and thereby increases contractile strength. Multinucleated osteoclasts have far more bone resorbing activity than their mono-nuclear counterparts. Multinucleated giant cells are much more efficient in the removal of implanted materials and bacteria due to chronic infection than macrophages. Therefore, they are also called foreign-body giant cells. Cell fusion is a complicated process involving cell migration, chemotaxis, cell-cell recognition and attachment, as well as changes into a fusion-competent status. All of these steps are regulated by multiple factors. In this review, we will discuss osteoclast fusion and regulation.

Entities:  

Keywords:  Bone resorption.; Dendritic cell-specific transmembrane protein; Fusion; Osteoclasts; Receptor activator of NF-κB ligand

Year:  2012        PMID: 23362465      PMCID: PMC3557323          DOI: 10.5312/wjo.v3.i12.212

Source DB:  PubMed          Journal:  World J Orthop        ISSN: 2218-5836


  84 in total

1.  CCN family 2/connective tissue growth factor (CCN2/CTGF) promotes osteoclastogenesis via induction of and interaction with dendritic cell-specific transmembrane protein (DC-STAMP).

Authors:  Takashi Nishida; Kenji Emura; Satoshi Kubota; Karen M Lyons; Masaharu Takigawa
Journal:  J Bone Miner Res       Date:  2011-02       Impact factor: 6.741

2.  NF-κB signaling participates in both RANKL- and IL-4-induced macrophage fusion: receptor cross-talk leads to alterations in NF-κB pathways.

Authors:  Minjun Yu; Xiulan Qi; Jose L Moreno; Donna L Farber; Achsah D Keegan
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

3.  Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes.

Authors:  Yong-Gil Kim; Chang-Keun Lee; Ji Seon Oh; Soo-Hyun Kim; Kyoung-A Kim; Bin Yoo
Journal:  Arthritis Rheum       Date:  2010-02

4.  The role of calcium release activated calcium channels in osteoclast differentiation.

Authors:  Yandong Zhou; Tricia L Lewis; Lisa J Robinson; Kathy M Brundage; Rosana Schafer; Karen H Martin; Harry C Blair; Jonathan Soboloff; John B Barnett
Journal:  J Cell Physiol       Date:  2011-04       Impact factor: 6.384

5.  Recent advances in understanding the mechanisms of osteoclast precursor fusion.

Authors:  Merry Jo Oursler
Journal:  J Cell Biochem       Date:  2010-08-01       Impact factor: 4.429

6.  NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.

Authors:  Zhenqiang Yao; Lianping Xing; Brendan F Boyce
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 7.  Regulation of osteoclast precursors in inflammatory bone loss.

Authors:  Lianping Xing
Journal:  Curr Opin Investig Drugs       Date:  2009-11

Review 8.  Molecular mediators of macrophage fusion.

Authors:  Laura Helming; Siamon Gordon
Journal:  Trends Cell Biol       Date:  2009-09-03       Impact factor: 20.808

9.  NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis.

Authors:  Chang Yang; Kathleen McCoy; Jennifer L Davis; Marc Schmidt-Supprian; Yoshiteru Sasaki; Roberta Faccio; Deborah Veis Novack
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

10.  ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo.

Authors:  Hisako Ishizuka; Verónica García-Palacios; Ganwei Lu; Mark A Subler; Heju Zhang; Christina S Boykin; Sun Jin Choi; Liena Zhao; Kenneth Patrene; Deborah L Galson; Harry C Blair; Tamer M Hadi; Jolene J Windle; Noriyoshi Kurihara; G David Roodman
Journal:  J Bone Miner Res       Date:  2011-01       Impact factor: 6.741

View more
  45 in total

1.  Modulation of unloading-induced bone loss in mice with altered ERK signaling.

Authors:  Jeyantt S Sankaran; Bing Li; Leah Rae Donahue; Stefan Judex
Journal:  Mamm Genome       Date:  2015-11-06       Impact factor: 2.957

2.  DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.

Authors:  W Wisitrasameewong; M Kajiya; A Movila; S Rittling; T Ishii; M Suzuki; S Matsuda; Y Mazda; M R Torruella; M M Azuma; K Egashira; M O Freire; H Sasaki; C Y Wang; X Han; M A Taubman; T Kawai
Journal:  J Dent Res       Date:  2017-02-15       Impact factor: 6.116

3.  Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.

Authors:  Hiroyuki Kanzaki; Alexandru Movila; Rayyan Kayal; Marcelo H Napimoga; Kenji Egashira; Floyd Dewhirst; Hajime Sasaki; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Martin A Taubman; Frank C Nichols; Toshihisa Kawai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-01-31       Impact factor: 4.698

4.  Osteoprotegerin exposure at different stages of osteoclastogenesis differentially affects osteoclast formation and function.

Authors:  Hongyan Zhao; Jianhong Gu; Nannan Dai; Qian Gao; Dong Wang; Ruilong Song; Wei Liu; Yan Yuan; Jianchun Bian; Xuezhong Liu; Zongping Liu
Journal:  Cytotechnology       Date:  2015-06-05       Impact factor: 2.058

5.  FOXO1 deletion reduces dendritic cell function and enhances susceptibility to periodontitis.

Authors:  Wenmei Xiao; Guangyu Dong; Sandra Pacios; Maher Alnammary; Laura A Barger; Yu Wang; Yingying Wu; Dana T Graves
Journal:  Am J Pathol       Date:  2015-04       Impact factor: 4.307

6.  Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation.

Authors:  Luz M Castillo; Carlos A Guerrero; Orlando Acosta
Journal:  J Mol Histol       Date:  2017-03-25       Impact factor: 2.611

7.  The Notch Ligand Jagged1 Regulates the Osteoblastic Lineage by Maintaining the Osteoprogenitor Pool.

Authors:  Rialnat A Lawal; Xichao Zhou; Kaylind Batey; Corey M Hoffman; Mary A Georger; Freddy Radtke; Matthew J Hilton; Lianping Xing; Benjamin J Frisch; Laura M Calvi
Journal:  J Bone Miner Res       Date:  2017-03-09       Impact factor: 6.741

8.  Inhibition mechanism of Qingluo Tongbi Granule () on osteoclast differentiation induced by synovial fibroblast and monocytes co-culture in adjuvant-induced arthritic rats.

Authors:  Tian-yang Liu; Ling-ling Zhou; Cong Zhou; Zhang-pu Liu; Chen Chen; Zhe Feng; Xue-ping Zhou
Journal:  Chin J Integr Med       Date:  2014-09-02       Impact factor: 1.978

9.  Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions.

Authors:  Mohammad Ahsanul Akbar; David Nardo; Mong-Jen Chen; Ahmed S Elshikha; Rubina Ahamed; Eslam M Elsayed; Claire Bigot; Lexie Shannon Holliday; Sihong Song
Journal:  Mol Med       Date:  2017-03-21       Impact factor: 6.354

10.  OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.

Authors:  Takenobu Ishii; Montserrat Ruiz-Torruella; Atsushi Ikeda; Satoru Shindo; Alexandru Movila; Hani Mawardi; Abdullah Albassam; Rayyan A Kayal; Ayman A Al-Dharrab; Kenji Egashira; Wichaya Wisitrasameewong; Kenta Yamamoto; Abdulghani I Mira; Kenji Sueishi; Xiaozhe Han; Martin A Taubman; Takeshi Miyamoto; Toshihisa Kawai
Journal:  FASEB J       Date:  2018-03-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.